Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce L Innis

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
The Pediatric Infectious Disease Journal|February 14, 2025
Infant Responses to Primary Immunization Following Vaccination in Pregnancy With Varying Doses of Recombinant Acellular Pertussis Vaccine Alone or Combined With Tetanus-DiphtheriaThanyawee Puthanakit, Kulkanya Chokephaibulkit, Suvaporn Anugulruengkitt, et al.
Journal of the Pediatric Infectious Diseases Society|September 4, 2015
Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical TrialJoanne M Langley, Long Wang, Naresh Aggarwal, et al.
The American Journal of Tropical Medicine and Hygiene|July 9, 2008
Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodiesJ Robert Putnak, Rafael de la Barrera, Timothy Burgess, et al.
NPJ Vaccines|March 20, 2021
AS03-adjuvanted H7N9 inactivated split virion vaccines induce cross-reactive and protective responses in ferretsDaniel Stadlbauer, Leon de Waal, Edith Beaulieu, et al.
The Journal of Infectious Diseases|December 11, 2012
Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccinesWellington Sun, Kenneth H Eckels, J Robert Putnak, et al.
Human Vaccines & Immunotherapeutics|March 5, 2019
Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regionsPhilippe Moris, Kristen M Bauer, Jeffrey R Currier, et al.
The American Journal of Tropical Medicine and Hygiene|May 29, 2014
Safety and immunogenicity of a rederived, live-attenuated dengue virus vaccine in healthy adults living in Thailand: a randomized trialVeerachai Watanaveeradej, Robert V Gibbons, Sriluck Simasathien, et al.
The American Journal of Tropical Medicine and Hygiene|March 8, 2018
Phase I Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto RicoClemente Diaz, Leyi Lin, Luis J Martinez, et al.
Journal of the Pediatric Infectious Diseases Society|November 20, 2015
Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 MonthsMaurice A Mufson, Clemente Diaz, Michael Leonardi, et al.
NPJ Vaccines|November 25, 2025
One year follow up of phase 1/2 randomized, placebo controlled trial of NDV-HXP-S vaccine in ThailandWeerapong Phumratanaprapin, Viravarn Luvira, Saranath Lawpoolsri, et al.
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
The Pediatric Infectious Disease Journal|February 14, 2025
Infant Responses to Primary Immunization Following Vaccination in Pregnancy With Varying Doses of Recombinant Acellular Pertussis Vaccine Alone or Combined With Tetanus-DiphtheriaThanyawee Puthanakit, Kulkanya Chokephaibulkit, Suvaporn Anugulruengkitt, et al.
Journal of the Pediatric Infectious Diseases Society|September 4, 2015
Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical TrialJoanne M Langley, Long Wang, Naresh Aggarwal, et al.
The American Journal of Tropical Medicine and Hygiene|July 9, 2008
Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodiesJ Robert Putnak, Rafael de la Barrera, Timothy Burgess, et al.
NPJ Vaccines|March 20, 2021
AS03-adjuvanted H7N9 inactivated split virion vaccines induce cross-reactive and protective responses in ferretsDaniel Stadlbauer, Leon de Waal, Edith Beaulieu, et al.
The Journal of Infectious Diseases|December 11, 2012
Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccinesWellington Sun, Kenneth H Eckels, J Robert Putnak, et al.
Human Vaccines & Immunotherapeutics|March 5, 2019
Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regionsPhilippe Moris, Kristen M Bauer, Jeffrey R Currier, et al.
The American Journal of Tropical Medicine and Hygiene|May 29, 2014
Safety and immunogenicity of a rederived, live-attenuated dengue virus vaccine in healthy adults living in Thailand: a randomized trialVeerachai Watanaveeradej, Robert V Gibbons, Sriluck Simasathien, et al.
The American Journal of Tropical Medicine and Hygiene|March 8, 2018
Phase I Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto RicoClemente Diaz, Leyi Lin, Luis J Martinez, et al.
Journal of the Pediatric Infectious Diseases Society|November 20, 2015
Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 MonthsMaurice A Mufson, Clemente Diaz, Michael Leonardi, et al.
NPJ Vaccines|November 25, 2025
One year follow up of phase 1/2 randomized, placebo controlled trial of NDV-HXP-S vaccine in ThailandWeerapong Phumratanaprapin, Viravarn Luvira, Saranath Lawpoolsri, et al.
Pageof 12